Machine learning fuels personalized cancer medicine
The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumor type.
Jul 29, 2021
0
159
The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumor type.
Jul 29, 2021
0
159
Researchers at UCL have developed a new way to deliver drugs that can shut down cancer-promoting mutations in neuroblastoma. The findings in mice, show the method, which uses tiny bubbles to deliver therapies directly to ...
Jul 28, 2021
0
228
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumors in mice. Their findings were published ...
Jul 22, 2021
0
12
A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumors, according to new research from the University of Warwick.
Jul 21, 2021
0
126
An aggressive type of cancer has provided a team of researchers supported by the Swiss National Science Foundation with an answer to the question of which tumor cells are at risk of spreading.
Jul 14, 2021
0
17
Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer at stages where the disease has spread to the bones.
Jul 7, 2021
0
20
Uppsala University scientists have designed a new mouse model that facilitates study of factors contributing to the progression of human bladder cancer and of immune-system activation when the tumor is growing. Using this ...
Jul 7, 2021
0
5
Researchers at Karolinska Institutet in Sweden have published new findings in the journal Cancer Discovery showing how pharmacological activation of the protein p53 boosts the immune response against tumours. The results ...
Jul 6, 2021
0
7
In recent years, immunotherapy has revolutionized the field of cancer treatment. However, inflammatory reactions in healthy tissues frequently trigger side effects that can be serious and lead to the permanent discontinuation ...
Jul 2, 2021
0
22
Scientists from the Francis Crick Institute and King's College London have studied colorectal cancer and found that levels of specific immune cells are the best predictors of whether immunotherapy will be effective in individual ...
Jun 30, 2021
1
6